AR123729A1 - IMPROVED DIAGNOSTIC TESTING - Google Patents

IMPROVED DIAGNOSTIC TESTING

Info

Publication number
AR123729A1
AR123729A1 ARP210102800A ARP210102800A AR123729A1 AR 123729 A1 AR123729 A1 AR 123729A1 AR P210102800 A ARP210102800 A AR P210102800A AR P210102800 A ARP210102800 A AR P210102800A AR 123729 A1 AR123729 A1 AR 123729A1
Authority
AR
Argentina
Prior art keywords
sequence
polypeptide
seq
diagnostic testing
improved diagnostic
Prior art date
Application number
ARP210102800A
Other languages
Spanish (es)
Inventor
Yasemin Ataman-Onal
Matthew Bonaparte
Catherine Chen
Vasco Liberal
Qilin Pan
Stephen Savarino
Wushan Yin
Lingyi Zheng
Original Assignee
Sanofi Pasteur
Ctk Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur, Ctk Biotech Inc filed Critical Sanofi Pasteur
Publication of AR123729A1 publication Critical patent/AR123729A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

La presente invención proporciona un dispositivo de prueba de inmunodiagnóstico para la detección de anticuerpos antivirus del dengue que comprende un primer antígeno del dengue y un segundo antígeno del dengue, en donde dicho primer antígeno del dengue comprende un polipéptido que tiene por lo menos 90% de identidad de secuencia con la SEQ ID Nº 1 y dicho segundo antígeno del dengue comprende un polipéptido que tiene la secuencia de la SEQ ID Nº 2 o un polipéptido que tiene una secuencia que tiene por lo menos 1 y no más de 4 sustituciones de aminoácidos en relación con la secuencia de la SEQ ID Nº 2.The present invention provides an immunodiagnostic test device for the detection of dengue virus antibodies comprising a first dengue antigen and a second dengue antigen, wherein said first dengue antigen comprises a polypeptide having at least 90% similarity. sequence identity with SEQ ID No. 1 and said second dengue antigen comprises a polypeptide having the sequence of SEQ ID No. 2 or a polypeptide having a sequence having at least 1 and no more than 4 amino acid substitutions in relation to the sequence of SEQ ID No. 2.

ARP210102800A 2020-10-07 2021-10-07 IMPROVED DIAGNOSTIC TESTING AR123729A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063088564P 2020-10-07 2020-10-07

Publications (1)

Publication Number Publication Date
AR123729A1 true AR123729A1 (en) 2023-01-04

Family

ID=85131231

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102800A AR123729A1 (en) 2020-10-07 2021-10-07 IMPROVED DIAGNOSTIC TESTING

Country Status (2)

Country Link
CN (1) CN117157524A (en)
AR (1) AR123729A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767324B1 (en) * 1997-08-14 2001-04-06 Pasteur Institut USE OF RECOMBINANT ENVELOPE PROTEINS FOR THE DIAGNOSIS OF DENGUE VIRUS
ATE521627T1 (en) * 2004-07-27 2011-09-15 Us Gov Health & Human Serv IDENTIFICATION OF CROSS-REACTIVE EPITOPES OF THE FLAVIVIRUS ENVELOPE GLYCOPROTEIN
PL2651975T3 (en) * 2010-12-14 2018-04-30 Dso Nat Laboratories HUMAN MONOCLONAL ANTIBODIES WITH RESPECTIVITY TO DENGA SEROTY 1 VIRUS PROTEIN AND ITS APPLICATION
GB2550418A (en) * 2016-05-20 2017-11-22 Laing Peter An improved vaccine against flaviviruses avoiding elicitation or stimulation of infection-enhancing antibodies

Also Published As

Publication number Publication date
CN117157524A (en) 2023-12-01

Similar Documents

Publication Publication Date Title
CO2022008396A2 (en) prame tcr receivers
JP2007520688A (en) Protein isolation method
BR112015008036A2 (en) isolated peptide population, method for detecting antibody in a sample, method for diagnosing monocytic and / or granulocytic erlichiosis, and kit
BR112016016737A2 (en) PEPTIDES, DEVICES AND METHODS FOR DETECTION OF ANTIBODIES AGAINST ANAPLASMA
SG11201810029PA (en) Immunochromatography Analysis Device for Detecting Zika Virus
Dung et al. Seroprevalence survey of avian influenza A (H5N1) among live poultry market workers in northern Viet Nam, 2011
MX2023014654A (en) A CONJUGATE.
BR112016021714A2 (en) immunoassay and antibodies for the detection of chromogranin at
BR112021008137A2 (en) Sensor
MX2023004087A (en) Improved diagnostic tests.
AR102966A1 (en) SPECIFIC MONOCLONAL ANTIBODIES FOR THE ANTIGEN M OF THE HUMAN METAPNEUMOVIRUS VIRUS (hMPV), PRODUCED AND SECRETED BY CELLULAR HYBRIDIDES, USEFUL FOR THE DETECTION AND DIAGNOSIS OF THE INFECTION CAUSED BY hMPV
AR125980A1 (en) ANTIBODIES SPECIFICALLY BOUND TO THE ASM PROTEIN
Murata et al. Seroprevalence of West Nile virus in wild birds in far eastern Russia using a focus reduction neutralization test
AR069047A1 (en) ANTIGENIC SYNTHETIC PEPTIDES AND LIPOPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS
ES2094252T3 (en) IMMUNE PREPARATION RELATED TO THE HUMAN IMMUNODEFICIENT VIRUS.
Di Germanio et al. A stable dried tube specimen for quality assurance and training programs for HIV rapid test for recent infection
Cabana et al. Serological monitoring of antibodies for an early diagnosis ofaspergillosis in captive penguins
AR130878A1 (en) SINGLE DOMAIN ANTIBODY - sdAb / Vhh AGAINST THE NUCLEOPROTEIN OF THE SARS-CoV-2 VIRUS
MX2022005611A (en) NEURON-SPECIFIC ANTIGENIC ENOLase PEPTIDES FOR THE DIAGNOSIS AND TREATMENT OF AUTISM.
SG10201801114XA (en) Recombinant baculoviruses and their uses in detecting arthropod borne virus
BR102016029385A2 (en) production of antigen for elisa-type testing using recombinant chicken infectious bronchitis virus nucleoprotein
Bonto et al. Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine
PL443854A1 (en) Epitope derived from the N protein of the SARS-CoV-2 virus, the antigen containing it, their uses and method of detecting the disease caused by the coronavirus
Kistler et al. Influenza A Virus H5–specific Antibodies in Mute Swans (Cygnus olor) in the USA
WO2020185165A3 (en) A method of identifying a flavivirus infection and related kits, peptides and compositions